News Published
In an interview with Börsvärlden, our CEO Martin Hillsten talks about the company's next phase. After a year marked by transformation, cost savings and a strengthened commercial organization, the company is now seeing the effects of that work – the 2025/26 fiscal year closed with the highest number of S1 surgeries performed in the company's history.
"Integrum has left a transformative phase and is now entering a phase with full focus on execution and growth," says Martin Hillsten in the interview.
In the conversation, he also discusses the shift toward a more data-driven commercial model, the launch of the digital patient portal in the US, and the Afyri initiative – an effort to accelerate the development of intelligent bionics.
Publicerad: 16 September, 2026
"We look forward to continuing to support Ukrainian hospitals and surgeons in building capacity and expertise...
Publicerad: 8 September, 2026
On Thursday September 3rd 2026, CEO Martin Hillsten and CFO Louise Wåhlin presented the company’s results...
Publicerad: 3 September, 2026
Read Integrum’s interim report for the first quarter of the company’s financial year.
Publicerad: 3 September, 2026
Comment
The first quarter of our new financial year clearly shows that Integrum continues to develop in the right...
Publicerad: 3 September, 2026